Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine, AFP reported Tuesday, citing the New York Times.
The facility in the Dutch city of Leiden halted output late last year, according to the report, which cited people familiar with the decision.
Read more